ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FMS Fresenius Medical Care AG

20.97
-0.69 (-3.19%)
03 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Fresenius Medical Care AG NYSE:FMS NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  -0.69 -3.19% 20.97 21.57 20.965 21.46 494,745 22:58:41

ADRs End Mostly Higher; Alibaba, Teva Trade Actively

07/08/2017 11:17pm

Dow Jones News


Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Fresenius Medical Care Charts.

International stocks trading in New York closed mostly higher Monday.

The BNY Mellon index of American depositary receipts increased 0.31% to 147.02. The Asian index improved 0.9% to 169.86. The Latin American index increased 0.91% to 240.67. And the emerging-markets index rose 1.28% to 312.96.

Meanwhile, the European index eased 0.05% to 137.77.

Alibaba Group Holding Ltd. (BABA) and Teva Pharmaceutical Industries Ltd. among those with ADRs that traded actively.

 

Alibaba said it would team up with U.S. hotel company Marriott International Inc. to expand its online-travel footprint as more residents from China venture abroad. ADRs rose 3.6% to $158.84.

 

Fresenius Medical Care AG (FMS, FME.XE) said on Monday it would acquire NxStage Medical Inc. for around $2 billion to bolster its kidney-dialysis business. The German company, which is the world's largest provider of dialysis products and services, said it would acquire all outstanding shares of NxStage for $30 each. The deal has been approved by NxStage's board, but still requires approval by NxStage stockholders and regulators, Fresenius Medical Care said in a statement. ADRs closed down 0.67% at $46.14.

 

ADRs of Teva Pharmaceutical Industries Ltd. (TEVA, TEVA.TV) fell 10% to $18.59 on Monday, after analysts at Morgan Stanley downgraded Teva to underweight and cut the price target on shares to $16 from $36. The latest analyst downgrade follows Teva's sluggish second-quarter earnings report and dividend cut last week.

 

(END) Dow Jones Newswires

August 07, 2017 18:02 ET (22:02 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

1 Year Fresenius Medical Care Chart

1 Year Fresenius Medical Care Chart

1 Month Fresenius Medical Care Chart

1 Month Fresenius Medical Care Chart

Your Recent History

Delayed Upgrade Clock